UMeWorld is a holding company that sells DAGola, a diacylglycerol (DAG)-based functional cooking oil, primarily in the U.S. through Amazon. DAG oil is metabolized as an energy source rather than stored as fat, and UMeWorld positions DAGola as a health-oriented alternative to conventional triglyceride-based cooking oils, targeting consumers focused on weight management and lipid health. Commercial operations run through its U.S. subsidiary, Dagola Inc., based in Miami, with no physical retail presence. UMeWorld has recently set up subsidiaries in Hong Kong and mainland China to support a planned Asia-Pacific expansion, though these entities are not yet operational. The company also has a pre-commercial biofuels initiative, Project Verdant, which involves evaluating a biodiesel pilot plant in Malaysia targeting the Sustainable Aviation Fuel market using waste-based feedstocks. Both the cooking oil and biofuels businesses share an enzymatic technology platform licensed from Guangzhou Yonghua, a Chinese partner that holds the underlying DAG know-how; UMeWorld holds exclusive commercialization rights outside China. The business is at an extremely early stage — revenues have been under $2,500 in each of the past three fiscal years — and the company funds itself entirely through external equity and debt financing. Its auditors have issued a going concern qualification. UMeWorld was originally founded as a pharma company, later pivoted to digital education in China, and launched DAGola on Amazon in 2022. It redomiciled from the British Virgin Islands to Delaware in October 2025.